Increasingly, private equity (PE) investors see physician practice management (PPM) and ASCs as attractive investment opportunities. This is because ASCs are well positioned to capitalize on some of the most important trends in healthcare, such as value-based care (VBC).
Private Equity
An affiliate of Capitol Pain Institute, an interventional pain management provider, and Iron Path Capital, a private equity firm, partnered to create a physician-led consolidation platform.
Four updates from private equity companies from the last 14 days:
The Federal Trade Commission has taken aim against a private-equity firms' healthcare deal in a move regulators say could spell trouble for other healthcare agreements the agency deems anticompetitive, The Wall Street Journal reported recently.
Private equity company Excelsior Capital has acquired a medical office building in Kansas City, Kan., for $7 million, the company said June 15.
Advertisement
Private equity-backed U.S. Urology Partners is adding Ormond Beach-based group practice Florida Urology Center.
Private equity has an increasing influence in the ASC industry as investors see opportunity in ASCs as a high-quality, low-cost site of service.
Private equity firms have long used ASCs as investment vehicles, which they have wrapped into larger portfolios and marketed to pension funds and other big institutional investors. But across the market, those institutions are reaching their capacity for such investments.
Many physicians who own their ASC and MOB real estate may be considering a sale-leaseback of their ASC/MOB real estate to take advantage of the increase in value of medical real estate.
From Gastro Health's sale to a private equity company to an anesthesia practice acquisition, here are eight private equity deals from the last year that ASC leaders need to know: